Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
AJANTPHARM Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and stable ROE
High and stable operating margin
Moderate EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Neutral
Moderate revenue growth and in line with median growth of industry
Moderate dividend yield
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
AJANTPHARM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
AJANTPHARM Bulk, Block & Insider Trades
AJANTPHARM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Others
Bonus(1 new shares for 2 existing shares) Ex-date: 22nd Jun 2022 Announced on: 10th May 2022
Bonus(1 new shares for 2 existing shares) Ex-date: 17th Sep 2013 Announced on: 29th Jul 2013
Stock split(2 : 5)Nominal value change from INR 5 to INR 2. Ex-date: 20th Mar 2015 Announced on: 28th Jan 2015
Stock split(1 : 2)AGM 07 July 2012. Nominal value changes from INR 10 to INR 5. Ex-date: 9th Aug 2012 Announced on: 26th Apr 2012
Share Buyback"On Market Tender offer. As on 27 June 2024 Total shares repurchased 1028881." Ex-date: 30th May 2024 Announced on: 2nd May 2024
Share Buyback"On Market Tender Offer. Total Amount Returned INR 3149962500.As of 19 April 2023 Shares repurchased 2210500." Ex-date: 24th Mar 2023 Announced on: 10th Mar 2023
Share Buyback Ex-date: 13th Jan 2022 Announced on: 28th Dec 2021
Share BuybackOn Market tender offer. Ex-date: 12th Nov 2020 Announced on: 3rd Nov 2020
Share Buyback"On Market Tender Offer. Total Amount Returned INR 100000000. Share Capital 0.87 percent currently. As of 30 January 2019Shares repurchased 769230." Ex-date: 11th Feb 2019 Announced on: 30th Jan 2019
Company Profile
Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia, and Africa. It has a wide range of... Read More
Key personnel
Mr. Mannalal Bhagwandas AgrawalD
Non-Executive Chairman of the Board
Mr. Madhusudan Bhagwandas AgrawalD
Executive Vice Chairman of the Board
Mr. Arvind K. Agrawal
Chief Financial Officer
Mr. Gaurang C. Shah
Vice President - Legal, Company Secretary
Mr. Rajesh Mannalal AgrawalD
Joint Managing Director, Executive Director
Mr. Yogesh Mannalal AgrawalD
Managing Director, Executive Director
Mr. Rajesh Shashikant DalalD
Additional Non-Executive Independent Director
Mrs. Medha Vinay JoshiD
Additional Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Ajanta Pharma Ltd.?
The current share price of Ajanta Pharma Ltd. is ₹ 2,766.13 as of 09 Jan 2026.
What is the PE ratio of Ajanta Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Ajanta Pharma Ltd. is 35.49 as of the latest financial data.
What is the ROE and ROCE of Ajanta Pharma Ltd.?
Ajanta Pharma Ltd. has a Return on Equity (ROE) of 24.37% and a Return on Capital Employed (ROCE) of 29.10% as per the latest financial reports.
What is the market cap of Ajanta Pharma Ltd.?
The market capitalization of Ajanta Pharma Ltd. stands at ₹ 34,558.90 Cr.
What is the dividend yield of Ajanta Pharma Ltd.?
The dividend yield of Ajanta Pharma Ltd. is 1.01% based on the current market price.
What is the RSI of Ajanta Pharma Ltd.?
The Relative Strength Index (RSI) of Ajanta Pharma Ltd. is 53.77.
What is the FII and DII holding in Ajanta Pharma Ltd.?
Foreign Institutional Investors (FII) hold 8.53% and Domestic Institutional Investors (DII) hold 17.31% of Ajanta Pharma Ltd. shares.
What sector does Ajanta Pharma Ltd. belong to?
Ajanta Pharma Ltd. operates in the Healthcare sector.
What is the beta of Ajanta Pharma Ltd. stock?
The beta of Ajanta Pharma Ltd. stock is 0.73, indicating its volatility relative to the broader market.
